import { Box, Typography } from "@mui/material";

export const metadata = {
  slug: "2026-04-11-reply-diabetes-cardio-antibiotic-drug-combinations",
  title: "Reply: Are My Diabetes, Heart, and Antibiotic Drugs Tested Together?",
  description:
    "A patient-centered reply to The Daily Brief's clinical-trials essay: new drugs are tested, some interactions are studied, but the exact diabetes-cardio-antibiotic stack a patient receives is often not tested as a full cocktail.",
  excerpt:
    "A patient-centered reply to The Daily Brief's clinical-trials essay: new drugs are tested, some interactions are studied, but the exact diabetes-cardio-antibiotic stack a patient receives is often not tested as a full cocktail.",
  tags: ["Reply", "Health", "Clinical Trials", "Drug Safety", "Polypharmacy", "India"],
  datePublished: "2026-04-11",
  dateModified: "2026-04-11",
  image: "/media/blogwordcloud.png",
  readingTime: "~5 min",
};

const title = "Reply: Are My Diabetes, Heart, and Antibiotic Drugs Tested Together?";

const sourceUrl =
  "https://thedailybrief.zerodha.com/p/can-the-pharmacy-of-the-world-test";

const tags = ["Reply", "Health", "Clinical Trials", "Drug Safety", "Polypharmacy", "India"];

const testedLayers = [
  "The individual drug is tested before approval: first in labs and animals, then in human clinical trials that move from small safety studies to larger efficacy and safety studies.",
  "Some drug-drug interactions are tested or modeled when there is a clear pharmacology reason: for example, whether a new drug is affected by common drug-metabolizing enzymes or transporters.",
  "Some large outcome trials include patients who are already on background therapy, such as diabetes and heart medicines. That helps, but it still does not prove every exact cocktail.",
  "After approval, regulators and companies keep watching adverse-event reports and other post-market safety data. That is how some safety signals become label warnings later.",
];

const gapReasons = [
  "The combinations explode too fast. Five diabetes drugs, five cardiac drugs, five antibiotics, two kidney-function bands, two age bands, and two dose levels already create thousands of possible cases before we even add dehydration, fever, liver function, or other medicines.",
  "Trials are built to answer a clean question. Did this drug work? Was it safer than the comparator? If every participant has a different medicine stack, the signal becomes harder to interpret.",
  "Ethics matters. You cannot expose humans or animals to arbitrary drug cocktails just because the math is interesting. There needs to be a plausible risk or a clinical reason.",
  "Animals are not a shortcut for lived polypharmacy. An animal study can identify mechanisms and toxicity, but it cannot reliably recreate an older human with diabetes, cardiac disease, infection, renal stress, diet changes, and ten years of prior treatment.",
  "Generic incentives are weak. Once a drug is cheap and off-patent, no single company has a strong commercial reason to fund every common real-world combination study.",
  "Antibiotics are temporary and messy. They are prescribed for different infections, durations, severities, and kidney-function states. The same antibiotic can be a low-risk choice in one patient and a poor choice in another.",
];

const patientQuestions = [
  "Has this antibiotic been checked against my diabetes medicines and heart medicines?",
  "Do I need extra blood-sugar monitoring while I am on it?",
  "Do I need a kidney-function or potassium check because of my current medicines?",
  "Is there a safer antibiotic option for my infection and my existing prescription list?",
  "Should any medicine be paused, dose-adjusted, or timed differently while the antibiotic is being taken?",
];

const betterSystem = [
  "Broader trial eligibility so people with common comorbidities are not automatically filtered out unless there is a good reason.",
  "Targeted interaction studies for common and high-risk stacks, not every theoretical stack.",
  "Prescription systems that flag antibiotic interactions against diabetes and cardiac medicines before the prescription is filled.",
  "Pharmacist-led medication review whenever an antibiotic is added to a chronic diabetes-cardio regimen.",
  "Indian real-world evidence using prescription, lab, hospitalization, and adverse-event data, with negative findings published instead of buried.",
];

const sources = [
  {
    label: "The Daily Brief by Zerodha: Can the pharmacy of the world test its own medicine?",
    url: sourceUrl,
  },
  {
    label: "FDA: Step 3 - Clinical Research",
    url: "https://www.fda.gov/patients/drug-development-process/step-3-clinical-research",
  },
  {
    label: "FDA: M12 Drug Interaction Studies",
    url: "https://www.fda.gov/regulatory-information/search-fda-guidance-documents/m12-drug-interaction-studies",
  },
  {
    label: "FDA: Enhancing Participation in Clinical Trials",
    url: "https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enhancing-participation-clinical-trials-eligibility-criteria-enrollment-practices-and-trial-designs",
  },
  {
    label: "FDA: Fluoroquinolone antibiotics and serious low blood sugar warning",
    url: "https://www.fda.gov/drugs/drug-safety-and-availability/fda-reinforces-safety-information-about-serious-low-blood-sugar-levels-and-mental-health-side",
  },
  {
    label: "FDA: FDA Adverse Event Reporting System",
    url: "https://www.fda.gov/drugs/surveillance/questions-and-answers-fdas-adverse-event-reporting-system-faers",
  },
  {
    label: "National Institute on Aging: Taking Medicines Safely as You Age",
    url: "https://www.nia.nih.gov/health/medicines-and-medication-management/taking-medicines-safely-you-age",
  },
];

const bodyTextSx = {
  fontSize: "1.125rem",
  lineHeight: 1.8,
  color: "var(--mui-palette-text-primary)",
};

const sectionIntroSx = {
  fontSize: "1.125rem",
  lineHeight: 1.8,
  color: "var(--mui-palette-text-secondary)",
};

const calloutSx = {
  borderLeft: "4px solid var(--mui-palette-primary-main)",
  pl: 2,
  py: 1.5,
  backgroundColor: "var(--mui-palette-action-hover)",
  borderRadius: 1,
};

export default function BlogPost() {
  return (
    <Box sx={{ display: "flex", flexDirection: "column", gap: 6 }}>
      <Box
        sx={{
          display: "flex",
          flexWrap: "wrap",
          gap: 1,
          alignItems: "center",
          justifyContent: "flex-start",
        }}
      >
        {tags.map((tag) => {
          const label = encodeURIComponent(tag.replace(/\s+/g, "_"));
          return (
            <Box
              key={tag}
              component="img"
              src={`https://img.shields.io/badge/${label}-2563EB?style=for-the-badge&labelColor=1F2937&logoColor=white`}
              alt={`${tag} badge`}
              loading="lazy"
              decoding="async"
              sx={{ height: 28, width: "auto" }}
            />
          );
        })}
      </Box>

      <Box component="section" sx={{ display: "flex", flexDirection: "column", gap: 2 }}>
        <Typography
          variant="h1"
          sx={{
            fontSize: { xs: "1.875rem", md: "2.5rem" },
            fontWeight: 700,
            lineHeight: 1.2,
            color: "var(--mui-palette-text-primary)",
          }}
        >
          {title}
        </Typography>
        <Typography variant="body1" sx={bodyTextSx}>
          Source:{" "}
          <Box
            component="a"
            href={sourceUrl}
            target="_blank"
            rel="noreferrer noopener"
            sx={{ color: "inherit" }}
          >
            {sourceUrl}
          </Box>
        </Typography>
        <Box sx={calloutSx}>
          <Typography variant="body1" sx={bodyTextSx}>
            The Daily Brief asks whether India can test its own medicine. My patient
            question is sharper: has anyone tested the medicine combination that
            actually reaches my bedside?
          </Typography>
        </Box>
        <Typography variant="body1" sx={bodyTextSx}>
          If I am on diabetes medicines and cardiac medicines, and then an antibiotic
          is added for an infection, I do not only care whether each pill passed its
          own exam. I care whether the whole stack has been tested together in a
          human, or at least in an animal model that means something.
        </Typography>
        <Typography variant="body1" sx={bodyTextSx}>
          The honest answer is uncomfortable: sometimes parts of the stack are studied,
          but the exact cocktail is usually not tested as a complete real-world package.
          This is not personal medical advice; it is the question I would want my doctor
          and pharmacist to answer before a new antibiotic is added.
        </Typography>
      </Box>

      <Box component="section" sx={{ display: "flex", flexDirection: "column", gap: 2 }}>
        <Typography variant="h2" sx={{ fontSize: { xs: "1.6rem", md: "2rem" }, fontWeight: 600 }}>
          What is usually tested
        </Typography>
        <Typography variant="body1" sx={sectionIntroSx}>
          The system is not blind. It is just narrower than the patient&apos;s lived reality.
        </Typography>
        <Box component="ul" sx={{ m: 0, pl: 3, display: "flex", flexDirection: "column", gap: 1.25 }}>
          {testedLayers.map((point) => (
            <Typography key={point} component="li" variant="body1" sx={bodyTextSx}>
              {point}
            </Typography>
          ))}
        </Box>
        <Box sx={calloutSx}>
          <Typography variant="body1" sx={bodyTextSx}>
            A useful example is the United States Food and Drug Administration&apos;s warning
            on fluoroquinolone antibiotics. It specifically calls out serious low blood
            sugar risk, especially in older people and patients with diabetes taking
            medicines to reduce blood sugar.
          </Typography>
        </Box>
      </Box>

      <Box component="section" sx={{ display: "flex", flexDirection: "column", gap: 2 }}>
        <Typography variant="h2" sx={{ fontSize: { xs: "1.6rem", md: "2rem" }, fontWeight: 600 }}>
          What is usually not tested
        </Typography>
        <Typography variant="body1" sx={sectionIntroSx}>
          The missing piece is not whether medicine is tested at all. It is whether my
          exact chronic-plus-acute combination has been tested.
        </Typography>
        <Typography variant="body1" sx={bodyTextSx}>
          A trial may tell us how a diabetes drug performs. Another may tell us how a
          cardiac drug performs. A drug-interaction study may test one antibiotic against
          one metabolic pathway. But a patient&apos;s prescription list is not a clean diagram.
          It is diabetes, cardiac risk, infection, age, kidney function, diet, fever,
          and sometimes dehydration arriving on the same day.
        </Typography>
        <Typography variant="body1" sx={bodyTextSx}>
          So if the question is, &quot;Has this exact diabetes-cardio-antibiotic combination
          been tested in humans or animals?&quot; the default answer should be: do not assume
          yes. Ask for the interaction check.
        </Typography>
      </Box>

      <Box component="section" sx={{ display: "flex", flexDirection: "column", gap: 2 }}>
        <Typography variant="h2" sx={{ fontSize: { xs: "1.6rem", md: "2rem" }, fontWeight: 600 }}>
          Why not?
        </Typography>
        <Typography variant="body1" sx={sectionIntroSx}>
          The reasons are not all excuses. Some are scientific, some ethical, and some economic.
        </Typography>
        <Box component="ul" sx={{ m: 0, pl: 3, display: "flex", flexDirection: "column", gap: 1.25 }}>
          {gapReasons.map((point) => (
            <Typography key={point} component="li" variant="body1" sx={bodyTextSx}>
              {point}
            </Typography>
          ))}
        </Box>
      </Box>

      <Box component="section" sx={{ display: "flex", flexDirection: "column", gap: 2 }}>
        <Typography variant="h2" sx={{ fontSize: { xs: "1.6rem", md: "2rem" }, fontWeight: 600 }}>
          The questions I would ask before swallowing the new pill
        </Typography>
        <Typography variant="body1" sx={sectionIntroSx}>
          This is where the abstract clinical-trials debate becomes a five-minute safety conversation.
        </Typography>
        <Box component="ul" sx={{ m: 0, pl: 3, display: "flex", flexDirection: "column", gap: 1.25 }}>
          {patientQuestions.map((point) => (
            <Typography key={point} component="li" variant="body1" sx={bodyTextSx}>
              {point}
            </Typography>
          ))}
        </Box>
        <Typography variant="body1" sx={bodyTextSx}>
          Those questions are not anti-medicine. They are pro-medicine. A good drug used
          casually in the wrong stack can become a bad experience.
        </Typography>
      </Box>

      <Box component="section" sx={{ display: "flex", flexDirection: "column", gap: 2 }}>
        <Typography variant="h2" sx={{ fontSize: { xs: "1.6rem", md: "2rem" }, fontWeight: 600 }}>
          What India should build
        </Typography>
        <Typography variant="body1" sx={sectionIntroSx}>
          The right answer is not to demand a trial for every possible cocktail. That would freeze medicine.
        </Typography>
        <Box component="ul" sx={{ m: 0, pl: 3, display: "flex", flexDirection: "column", gap: 1.25 }}>
          {betterSystem.map((point) => (
            <Typography key={point} component="li" variant="body1" sx={bodyTextSx}>
              {point}
            </Typography>
          ))}
        </Box>
        <Typography variant="body1" sx={bodyTextSx}>
          That is the patient-side version of The Daily Brief&apos;s argument. India should
          not only become better at testing new molecules. It should become better at
          learning from the medicine combinations Indians actually take.
        </Typography>
        <Box sx={calloutSx}>
          <Typography variant="body1" sx={bodyTextSx}>
            The gap is not that we know nothing. The gap is that the prescription is
            personal, while the evidence is often averaged.
          </Typography>
        </Box>
      </Box>

      <Box component="section" sx={{ display: "flex", flexDirection: "column", gap: 2 }}>
        <Typography variant="h2" sx={{ fontSize: { xs: "1.6rem", md: "2rem" }, fontWeight: 600 }}>
          Sources
        </Typography>
        <Box component="ul" sx={{ m: 0, pl: 3, display: "flex", flexDirection: "column", gap: 1 }}>
          {sources.map((source) => (
            <Typography key={source.url} component="li" variant="body1" sx={bodyTextSx}>
              <Box
                component="a"
                href={source.url}
                target="_blank"
                rel="noreferrer noopener"
                sx={{ color: "inherit" }}
              >
                {source.label}
              </Box>
            </Typography>
          ))}
        </Box>
      </Box>
    </Box>
  );
}
